BICYCLE THERAPEUTICS PLC Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Bicycle Therapeutics Plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q2 2024.
  • Bicycle Therapeutics Plc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$39.8M, a 6.55% increase year-over-year.
  • Bicycle Therapeutics Plc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$165M, a 18.1% decline year-over-year.
  • Bicycle Therapeutics Plc annual Net Income (Loss) Attributable to Parent for 2023 was -$181M, a 60.3% decline from 2022.
  • Bicycle Therapeutics Plc annual Net Income (Loss) Attributable to Parent for 2022 was -$113M, a 68.7% decline from 2021.
  • Bicycle Therapeutics Plc annual Net Income (Loss) Attributable to Parent for 2021 was -$66.8M, a 31% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$165M -$39.8M +$2.79M +6.55% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$168M -$26.6M +$12.5M +32% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-06
Q4 2023 -$181M -$49.1M -$19.1M -63.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 -$162M -$49.9M -$21.6M -76% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 -$140M -$42.6M -$15.8M -58.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$124M -$39.1M -$11.5M -41.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-06
Q4 2022 -$113M -$30M -$11.9M -66.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 -$101M -$28.3M -$13.7M -93.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$87.1M -$26.8M -$8.92M -49.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-02
Q1 2022 -$78.2M -$27.6M -$11.4M -70.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-02
Q4 2021 -$66.8M -$18M -$604K -3.47% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 -$66.2M -$14.7M -$4.54M -44.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$61.7M -$17.9M -$5.8M -47.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-03
Q1 2021 -$55.9M -$16.2M -$4.87M -43% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-03
Q4 2020 -$51M -$17.4M -$13M -296% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-11
Q3 2020 -$38M -$10.1M -$656K -6.92% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$37.3M -$12.1M -$1.9M -18.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-04
Q1 2020 -$35.4M -$11.3M -$4.82M -74.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-04
Q4 2019 -$30.6M -$4.41M +$2.24M +33.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$32.8M -$9.48M -$1.79M -23.3% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-11
Q2 2019 -$31.1M -$10.2M -$5.24M -105% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-11
Q1 2019 -$25.8M -$6.5M -$3.97M -157% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-11
Q4 2018 -$21.8M -$6.64M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 -$7.69M Jul 1, 2018 Sep 30, 2018 10-K 2020-03-10
Q2 2018 -$4.98M Apr 1, 2018 Jun 30, 2018 10-K 2020-03-10
Q1 2018 -$2.53M Jan 1, 2018 Mar 31, 2018 10-K 2020-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.